Home Compliance Life Sciences Companies Face Continuing Compliance Challenges in Developing Value-Based and Value-Added... ComplianceExpert Opinion Life Sciences Companies Face Continuing Compliance Challenges in Developing Value-Based and Value-Added Models January 5, 2024 38 H_Ko | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Compliance Kickbacks and Claims: Relator’s Case for Genetic Test Fraud Falters on Particularity Law CICA Stay Preserved: COFC Rules in Favor of Protester, Applies Equitable Tolling Compliance First Circuit Holds Relator’s Claims Failed to Meet FCA Standards